adalimumab
abbvie
['crohn', 'adalimumab', 'ibd']
linschoten - adalimumab dose reduction trial in #crohnsdisease in remission; increasing dose interval noninferior to std therapy for persistent flares but more likely to need rescue therapy (not surprisingly); more gi adverse events in the dose reduction group #uegweek22 #ibd
Swedish physician specializing in the treatment of Crohn's disease and Ulcerative Colitis. Views - my own.